PerkinElmer, Inc. Expands Reagent Portfolio to Accelerate Biotherapeutics Drug Development

Published: Dec 11, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of a new range of assay kits utilizing AlphaLISA® technology to help improve the safety testing, manufacturing and quality control of biotherapeutic drugs.

Back to news